Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability...
Microdose
Tue, Nov 28
Vancouver, British Columbia, November 28, 2023 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and